Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 1
1996 1
1998 1
1999 1
2002 1
2006 1
2009 1
2011 3
2013 2
2014 2
2015 3
2016 3
2017 2
2018 3
2019 1
2020 1
2021 3
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.
Maurer MJ, Ghesquières H, Jais JP, Witzig TE, Haioun C, Thompson CA, Delarue R, Micallef IN, Peyrade F, Macon WR, Jo Molina T, Ketterer N, Syrbu SI, Fitoussi O, Kurtin PJ, Allmer C, Nicolas-Virelizier E, Slager SL, Habermann TM, Link BK, Salles G, Tilly H, Cerhan JR. Maurer MJ, et al. Among authors: syrbu si. J Clin Oncol. 2014 Apr 1;32(10):1066-73. doi: 10.1200/JCO.2013.51.5866. Epub 2014 Feb 18. J Clin Oncol. 2014. PMID: 24550425 Free PMC article. Clinical Trial.
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes.
Castellino A, Wang Y, Larson MC, Maurer MJ, Link BK, Farooq U, Feldman AL, Syrbu SI, Habermann TM, Paludo J, Inwards DJ, Witzig TE, Ansell SM, Allmer C, Slager SL, Cohen JB, Martin P, Cerhan JR, Nowakowski GS. Castellino A, et al. Among authors: syrbu si. Blood Adv. 2022 Feb 22;6(4):1350-1360. doi: 10.1182/bloodadvances.2021005715. Blood Adv. 2022. PMID: 34662895 Free PMC article.
Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma.
Luchtel RA, Zimmermann MT, Hu G, Dasari S, Jiang M, Oishi N, Jacobs HK, Zeng Y, Hundal T, Rech KL, Ketterling RP, Lee JH, Eckloff BW, Yan H, Gaonkar KS, Tian S, Ye Z, Kadin ME, Sidhu J, Jiang L, Voss J, Link BK, Syrbu SI, Facchetti F, Bennani NN, Slager SL, Ordog T, Kocher JP, Cerhan JR, Ansell SM, Feldman AL. Luchtel RA, et al. Among authors: syrbu si. Blood. 2019 Jun 27;133(26):2776-2789. doi: 10.1182/blood.2019000626. Epub 2019 May 17. Blood. 2019. PMID: 31101622 Free PMC article.
Destructive soft tissue mass in the maxilla/maxillary sinus.
Lanzel E, Syrbu SI, Hellstein JW, Stein KM, Welander S, Sousa Melo SL. Lanzel E, et al. Among authors: syrbu si. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):510-515. doi: 10.1016/j.oooo.2016.10.020. Epub 2016 Nov 2. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018. PMID: 28089462 No abstract available.
Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma.
Oishi N, Hundal T, Phillips JL, Dasari S, Hu G, Viswanatha DS, He R, Mai M, Jacobs HK, Ahmed NH, Syrbu SI, Salama Y, Chapman JR, Vega F, Sidhu J, Bennani NN, Epstein AL, Medeiros JL, Clemens MW, Miranda RN, Feldman AL. Oishi N, et al. Among authors: syrbu si. Haematologica. 2021 Jun 1;106(6):1714-1724. doi: 10.3324/haematol.2019.245860. Haematologica. 2021. PMID: 32414854 Free PMC article.
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.
Cerhan JR, Link BK, Habermann TM, Maurer MJ, Feldman AL, Syrbu SI, Thompson CA, Farooq U, Novak AJ, Slager SL, Allmer C, Lunde JJ, Macon WR, Inwards DJ, Johnston PB, Micallef INM, Nowakowski GS, Ansell SM, Kay NE, Weiner GJ, Witzig TE. Cerhan JR, et al. Among authors: syrbu si. Int J Epidemiol. 2017 Dec 1;46(6):1753-1754i. doi: 10.1093/ije/dyx119. Int J Epidemiol. 2017. PMID: 29025017 Free PMC article. No abstract available.
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
Maurer MJ, Bachy E, Ghesquières H, Ansell SM, Nowakowski GS, Thompson CA, Inwards DJ, Allmer C, Chassagne-Clément C, Nicolas-Virelizier E, Sebban C, Lebras L, Sarkozy C, Macon WR, Feldman AL, Syrbu SI, Traverse-Glehan A, Coiffier B, Slager SL, Weiner GJ, Witzig TE, Habermann TM, Salles G, Cerhan JR, Link BK. Maurer MJ, et al. Among authors: syrbu si. Am J Hematol. 2016 Nov;91(11):1096-1101. doi: 10.1002/ajh.24492. Epub 2016 Sep 3. Am J Hematol. 2016. PMID: 27465588 Free PMC article.
30 results